Clinical trial
Tolerability of Nebivolol Compared With Metoprolol ER in Patients With Mild to Moderate Hypertension Taking Hydrochlorothiazide (HCTZ)
NCT00547300 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability of Nebivolol Compared With Metoprolol ER in Patients With Mild to Moderate Hypertension Taking Hydrochlorothiazide (HCTZ)
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 31, 2007
- Completion date
- January 2, 2008
- Enrollment
- 49 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.